NRX PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$2.27
-14.66%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-20.4%
3 months
-29.9%
6 months
-26.5%
1 year
-24.8%
Year to date
-16.2%
52-week range
$1.68 – $4.62
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$98.3M
P/E
-4.2
P/B
-578.2
P/S
29
Revenue
$3.39M
Net income
-$23.48M
Diluted EPS
-0.55
Gross margin
46.60%
Net margin
-691.80%
Return on equity
168.70%
Total debt
$1.25M
Cash
$26.69M
Free cash flow
-$20.67M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $1.1M | -$16.52M | 38.70% | -1500.50% | -$9.77M |
| Mar 31, 2026 | $1.07M | -$1.43M | 40.90% | -133.90% | -$4.3M |
| Dec 31, 2025 | $983K | $360K | 58.50% | 36.60% | -$3.71M |
| Sep 30, 2025 | $242K | -$5.89M | 59.90% | -2433.90% | -$2.89M |
| Jun 30, 2025 | $0 | -$17.58M | — | — | -$4.03M |
| Mar 31, 2025 | $0 | -$5.51M | — | — | -$3.48M |
| Dec 31, 2024 | $0 | -$9.08M | — | — | -$2.1M |
| Sep 30, 2024 | $0 | -$1.62M | — | — | -$2.31M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent NRXP news
All market newsNo ticker-linked stories are in the current archive.